Highest-materiality recent filing
Bunge Q2 adjusted EPS $2.00 beats $1.31; raises FY outlook to $9.25-$9.75
Q2 GAAP diluted EPS $3.47 vs $2.61 prior year; adjusted EPS $2.00 vs $1.31.
Bunge Q1 adjusted EPS $1.83 beats prior year; raises FY outlook to $9.00-9.50
Q1 GAAP diluted EPS $0.35 vs $1.48 prior year; adjusted EPS $1.83 vs $1.81.
Bunge Global SA grants PBRSUs to execs tied to Viterra integration synergy targets
CEO Gregory Heckman receives 63,281 PBRSUs; CFO John Neppl receives 12,099; COO Garros 19,501.
Bunge files Viterra H1 2025 financials; Viterra reports $199M net loss on $20.97B revenue
Viterra H1 2025 revenue $20,974M (down 7% YoY from $22,572M); net loss $199M vs income $70M.
Bunge FY2025 GAAP EPS $4.93 (down 38%); Q4 adjusted EPS $1.99 near prior $2.13
Full-year GAAP diluted EPS $4.93 vs $7.99; adjusted $7.57 vs $9.19.
Bunge Global SA COO David Mattiske steps down; Julio Garros becomes sole COO effective Dec 12, 2025
David Mattiske resigns as co-Chief Operating Officer effective Dec 11, 2025, to pursue other professional opportunities.
Q3 GAAP diluted EPS $0.86 vs $1.56 YoY; adjusted EPS $2.27 vs $2.29.
Bunge changes segment reporting and recasts 2025 outlook after Viterra combination
Oilseeds realigned into Soybean Processing and Refining, Softseed Processing and Refining, and Other Oilseeds Processing and Refining.
Bunge Q2 GAAP EPS $2.61, adjusted $1.31; merger with Viterra completed
GAAP diluted EPS $2.61 vs $0.48 prior year; net income $354M vs $70M.
Bunge completes Viterra acquisition; exchange offers expire, settlement July 8
Business combination with Viterra closed on July 2, 2025.
Bunge completes merger with Viterra, creating global agribusiness solutions company
Bunge acquired all outstanding Viterra shares, issuing 65.6M shares valued at ~$5.3B plus $2B cash to Sellers.
Bunge borrows $2B via term loan to fund Viterra acquisition; matures 2028
BLFC enters $2B term loan agreement with Sumitomo Mitsui Banking Corp as administrative agent; matures June 1, 2028.
Bunge-Viterra merger closing set for July 2, 2025; Chinese, Mexican antitrust approvals received
Closing date mutually agreed as July 2, 2025, subject to satisfaction of remaining conditions.
Bunge extends Viterra note exchange offer to July 3, 2025, pending acquisition close
Expiration date extended from June 13 to July 3, 2025, for exchange of up to $1.95B in Viterra notes.
Bunge Q1 adj EPS $1.81 vs $3.04 YoY; maintains FY guidance ~$7.75
GAAP diluted EPS $1.48 vs $1.68 prior year; adjusted EPS $1.81 vs $3.04.
Bunge FY2024 adjusted EPS $9.19 vs $13.66; Q4 adjusted EPS $2.13 vs $3.70
Full-year GAAP diluted EPS $7.99 (2023: $14.87); adjusted EPS $9.19 vs $13.66.
Bunge expands share repurchase program with additional $500M authorization to ~$1.3B total
Board authorized an additional $500M in share repurchases on November 13, 2024.
Bunge extends Viterra note exchange offers to Jan 2, 2025; 94-99% tendered
Exchange offer expiration extended from Oct 31, 2024 to Jan 2, 2025; all terms unchanged.
Bunge Q3 adjusted EPS $2.29 vs $2.99 YoY; full-year guidance at least $9.25
Q3 GAAP diluted EPS $1.56 vs $2.47; adjusted EPS $2.29 vs $2.99 in prior year.
Bunge extends Viterra note exchange offers to Oct 31; tender rates high
BLFC extends expiration date from Oct 7 to 5:00 p.m. NY time on Oct 31, 2024.
Bunge sells 50% stake in BP Bunge Bioenergia JV for ~$828M net
Sold 50% ownership in BP Bunge Bioenergia (sugar/ethanol JV) to BP affiliate for approx. $828M net.
Bunge prices $2.0B senior notes offering in three tranches to fund Viterra acquisition
$400M 4.100% notes due 2028, $800M 4.200% notes due 2029, $800M 4.650% notes due 2034.
Bunge files Viterra FY2023 financials: revenue $54.7B, net income $453M (down 56% YoY)
Viterra 2023 revenue $54,673M; net income $453M vs $1,042M in 2022; gross margin $1,702M.
Bunge subsidiary launches up to $1.95B exchange offer for Viterra notes pending acquisition
BLFC offers to exchange all Viterra notes (2026/2027/2031/2032) for new Bunge-guaranteed notes plus $1 cash per $1,000.
Bunge Q2 adjusted EPS $1.73 vs $3.72; GAAP EPS $0.48; cuts FY outlook to ~$9.25
Q2 GAAP diluted EPS $0.48 (down 88% vs $4.09); adjusted EPS $1.73 (down 54% vs $3.72).
Bunge to sell 50% stake in BP Bunge Bioenergia JV for ~$800M
Bunge will sell its 50% interest in the BP Bunge Bioenergia JV to BP for an estimated net $800M.
Richard James will succeed Mr. Simmons as the Company's Controller and CAO effective as of April 1, 2027.
Matt Simmons notified the Company of his intention to retire as the Company’s Controller and Chief Accounting Officer (“CAO”) effective March 31, 2027.
Max materiality 1.00 · Median 0.60 · Most common event debt